Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

197
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
197
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

175
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

18
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
18
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

270
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
270
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

399
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
399
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

34
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.

Proceedings of the National Academy of Sciences of the United States of America·2012
Same author

Biosynthesis of ethyl oleate, a primer pheromone, in the honey bee (Apis mellifera L.).

Insect biochemistry and molecular biology·2012
Same author

Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.

Current drug metabolism·2012
Same author

Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2012
Same author

Expression profile analysis of the polygalacturonase-inhibiting protein genes in rice and their responses to phytohormones and fungal infection.

Plant cell reports·2012
Same author

Characterizing natural dissolved organic matter in a freshly submerged catchment (Three Gorges Dam, China) using UV absorption, fluorescence spectroscopy and PARAFAC.

Water science and technology : a journal of the International Association on Water Pollution Research·2012

Related Experiment Video

Updated: Sep 1, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.4K

Current therapy option for necrotizing enterocolitis: Practicalities and challenge.

Huihuan Wu1,2, Kehang Guo1,2, Zewei Zhuo1,3

  • 1Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Frontiers in Pediatrics
|August 15, 2022
PubMed
Summary
This summary is machine-generated.

Necrotizing enterocolitis (NEC), a common neonatal gut disorder, still has high mortality. Recent advances in therapies like stem cell therapy and fecal microbiota transplantation (FMT) offer new insights for NEC treatment and prevention.

Keywords:
breast milk compositionfecal microbiota transplantationimmunotherapynecrotizing enterocolitisstem cell

More Related Videos

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.5K
A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

7.8K

Related Experiment Videos

Last Updated: Sep 1, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.4K
Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.5K
A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

7.8K

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Pediatric Surgery

Background:

  • Necrotizing enterocolitis (NEC) is a leading cause of mortality in premature infants.
  • Despite advances, NEC incidence and mortality rates remain a significant clinical challenge.
  • Current management strategies for NEC require further improvement.

Purpose of the Study:

  • To review and analyze recent therapeutic advancements for NEC.
  • To discuss the potential clinical applicability of novel NEC treatments.
  • To provide insights into future directions for NEC prevention and management.

Main Methods:

  • Literature review of recent studies on NEC therapeutic approaches.
  • Analysis of emerging treatments including immunotherapy, stem cell therapy, and FMT.
  • Discussion of the evidence supporting novel NEC interventions.

Main Results:

  • Emerging therapies like stem cell therapy and fecal microbiota transplantation (FMT) show promise in preclinical and early clinical studies.
  • Administration of specific breast milk compositions is being explored for NEC prevention.
  • Immunotherapy presents a potential avenue for modulating the inflammatory response in NEC.

Conclusions:

  • Novel therapeutic strategies are evolving the landscape of NEC prevention and treatment.
  • Further research is needed to establish the efficacy and safety of these advanced NEC therapies.
  • These advancements hold the potential to significantly reduce NEC-related morbidity and mortality.